Rebalix
iShares · sheet of 5 September 2026
iShares · sheet of 5 September 2026ETF sheet · official issuer and register data
iShares JP Morgan Advanced $ EM Bond UCITS ETF
EMSA · IE00BF553838 · USD · domicile Ireland
Bonds · Government · Broad (all maturities) · Emerging marketsSFDR art. 8
Index tracked: JPM Screened Tilted & Reweighted EMBI Global Dvsd Index (JSTAR EMBI)
- TER
- 0.45%+ trans. 0.02%
- Fund size
- 1.1 bn EUR
- Tracking difference
- −0.26%3-year avg
- 🇮🇹 tax rate
- 17.16%white list 65.46%
- Replication
- Physical (optimised)
- Income
- Accumulating
- Duration
- 6.36 yrsmedium (3–7 years)
Launch 24 Sept 2018 · costs from the KID as of 2 Sept 2026 · 808 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the J.P. Morgan Screened, Tilted and Re-weighted EMBI Global Diversified Index, the Fund’s benchmark index (“Index”). The Share Class, via the Fund, is passively managed and aims to invest, so far as possible and practicable, in the fixed income (“FI”) securities (such as bonds) that make up the Index. The Index measures the performance of a sub-set of US Dollar…
Performance since series start (in euro) — base 100
24 Sept 2018 → 31 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +6.5% |
| 3 years | +19.6% |
| 5 years | +7.0% |
| 10 years | series too young |
| Since series start | +29.2% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 4.19% | 4.95% | 6.34% |
| Max drawdown | −3.91% | −5.43% | −28.88% |
| Sharpe | 0.83 | 1.02 | -0.21 |
| Sortino | 1.26 | 1.53 | -0.29 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · EMSA · IE00BF5538381
RebalixEMSA · IE00BF553838 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +13.05% | +13.26% | −0.22% |
| 2024 | +5.52% | +5.75% | −0.22% |
| 2023 | +9.91% | +10.26% | −0.35% |
| 2022 | −18.50% | −18.92% | +0.42% |
| 2021 | −2.83% | −2.35% | −0.48% |
Fixed income — as declared by the issuer
Issuer page · 20 Aug 2026 · investment-grade share (BBB−/Baa3 and above): 52.4%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Holdings
Portfolio as declared by the issuer · 31 Aug 2026 · 808 securities · top-10 weight = 6.9%
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
EMSA · Borsa Italiana (ETFplus), Euronext Amsterdam
SLME · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
+ 5 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BF553838
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BF553838
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · EMSA · IE00BF5538382